Idiopathic subglottic stenosis
MONDO:095809911 clinical trials for this condition and its sub-types, 7 tagged with Idiopathic subglottic stenosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
Could a biologic drug spare patients from repeat throat surgeries?
Disease control CompletedThis phase 2 trial tested the drug Taltz (ixekizumab) in 10 people with idiopathic subglottic stenosis, a rare condition where scar tissue narrows the airway. The goal was to see if blocking IL-17A could slow scar formation and lengthen the time between needed surgeries. Particip…
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a transplant drug keep a rare airway disease at bay?
Disease control CompletedThis early-phase trial tested whether the immunosuppressant drug everolimus could help people with idiopathic subglottic stenosis, a rare condition where scarring narrows the airway. Eight participants took everolimus for 42 days after a dilation surgery to open the airway. The g…
Early phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC